CAS: 13867-82-8; Cloxotestosterone Acetate

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2025281509-A1
      优先权日:2021-04-26
      标 题 :Sequential hormone therapy to improve survival and enhance response to immune therapy in men with prostate cancer
      发明人:DENMEADE SAMUEL R; ISAACS JOHN T; ANTONARAKIS EMMANUEL S; KACHHAP SUSHANT; MARKOWSKI MARK CHRISTOPHER
      权利人:UNIV JOHNS HOPKINS
      摘要:Disclosed are methods for treating men with castrate resistant prostate cancer with a sufficient dose of testosterone to achieve supraphysiologic serum levels of testosterone in sequence with androgen ablative treatment or androgen synthesis inhibitors for one or more cycles until evidence of radiographic progression, at which point the subject will receive immune checkpoint blockade therapy.

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知